Currently, under existing intellectual property laws in most jurisdictions, an AI cannot legally be named as an inventor on a […]

Implementation of Canada’s Patent Linkage System: Balancing Innovation and Market Access Canada’s patent linkage system represents a critical intersection of

In the intricate and high-stakes world of global pharmaceuticals, a seismic shift is underway. For decades, the industry has been

Introduction: Understanding the Evolving Role of Pharmacy Benefit Managers Pharmacy Benefit Managers (PBMs) are third-party companies that operate as intermediaries

In today’s competitive pharmaceutical landscape, the ability to accurately predict generic drug launches represents a critical strategic advantage for both

Patent filings represent one of the most valuable yet underutilized sources of competitive intelligence in the pharmaceutical industry. By systematically

The pharmaceutical landscape is shaped by a delicate balance between innovation and accessibility. While new drug development drives medical advancement,

In today’s competitive pharmaceutical landscape, Contract Development and Manufacturing Organizations (CDMOs) must leverage every available advantage to attract and retain

The pharmaceutical industry operates in a complex landscape where strategic intelligence can mean the difference between market leadership and obsolescence.